SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mendez, M. F.
Right arrow Articles by McMurtray, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendez, M. F.
Right arrow Articles by McMurtray, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Frontotemporal Dementia-like Phenotypes Associated With Presenilin-1 Mutations

Mario F. Mendez, MD, PhD

Neurobehavior Unit, 116AF, Building 500, 3S, VA Greater Los Angeles Healthcare, Los Angeles, CA 90073; mmendez{at}ucla.edu

Aaron McMurtray, MD

Frontal behavioral changes may be the presenting features of single-photon emission tomography (presenilin-1 [PS-1]) mutations, the most common cause of familial Alzheimer's disease (AD). The authors describe a PS-1 (M233L) mutation with the features of frontotemporal dementia (FTD) and review the literature. PS-1 mutations may produce FTD-like phenotypes with the neuropathology of AD. Some PS-1 mutations have additional Pick's bodies, a neuropathological marker of FTD, and a report of a PS-1 (G183V) mutation found Pick's bodies without amyloid plaques. The patient and the literature suggest that PS-1 mutations result in an overlapping continuum of the clinical and neuropathological features of AD and FTD. In PS-1 mutations, the expression of AD or FTD may depend on the degree of loss of function of the PS-1 gene and the resultant {tau} pathophysiology.

Key Words: presenilin-1 • Alzheimer's disease • frontotemporal dementia • {tau} • Pick's bodies

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 21, No. 4, 281-286 (2006)
DOI: 10.1177/1533317506290448


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
A. Robles, M.J. Sobrido, M. Garcia-Murias, J.M. Prieto, M. Lema, D. Santos, and M. Paramo
Clinical Picture of a Patient With a Novel PSEN1 Mutation (L424V)
American Journal of Alzheimer's Disease and Other Dementias, February 1, 2009; 24(1): 40 - 45.
[Abstract] [PDF]



Advertisement